BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  Akebia Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

  Akebia Therapeutics announced that the Company granted three newly-hired employees options to purchase an aggregate of 45,500 shares of Akebia’s common stock with a per share exercise price of $15.56, the closing price on the grant date.

  December 1, 2017

   · 

  1 min read
• Business

  Helix BioPharma COO Steps Down Due to Personal Reasons

  Helix BioPharma announced Steve Demas, its Chief Operating Officer, has resigned due to personal reasons.

  December 1, 2017

   · 

  1 min read
• LexaGene Completes Prototype Assembly for Soon-To-Be First Fully Automated, Open-Access Pathogen Detection System

  LexaGene has completed the assembly of its prototype for what will be the world’s first fully automated, open-access and on-site pathogen detection platform.

  December 1, 2017

   · 

  4 min read
• MabVax Stockholders Approve Proposals at Special Meeting of Stockholders

  MabVax today announced that its stockholders approved all proposals at a Special Meeting of Stockholders re-convened on December 1, 2017, after achieving a quorum on the proposals to be approved.

  December 1, 2017

   · 

  4 min read
• Trillium Announces Closing of Private Placement

  Trillium announced the closing of its non-brokered private placement, previously announced on November 15, 2017, of 1,950,000 common shares and 400,000 Series II non-voting convertible first preferred shares at a price of U.S.$8.50 per share for gross proceeds of U.S.$19,975,000.

  December 1, 2017

   · 

  4 min read
• Business

  Corindus Partners With Houston Methodist DeBakey Heart & Vascular Center to Launch Premier Robotic Training Site for Physicians

  Houston Methodist DeBakey Heart & Vascular Center has launched the first vascular robotic program in the Houston area with the installation of two CorPath® GRX Systems.

  December 1, 2017

   · 

  6 min read
• Policy

  Aradigm Announces FDA Advisory Committee Meeting for Linhaliq

  Aradigm Corporation announced that a meeting of the Antimicrobial Drugs Advisory Committee of the FDA has been scheduled for January 11, 2018 to review the Company’s New Drug Application (NDA) for Linhaliq.

  December 1, 2017

   · 

  3 min read
• Business

  EMD Serono Appoints Zhen Su, M.D., MBA to CMO, North America

  In this role, Dr. Su will collaborate with the local and global medical, development and regulatory teams to drive the progress of EMD Serono’s portfolio and pipeline, as well as enhance scientific leadership in the US.

  December 1, 2017

   · 

  3 min read
• Business

  Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA (isavuconazole) in China and Asia Pacific Region

  Pfizer and Basilea Pharmaceutica announced they have entered into an agreement whereby Pfizer will be granted the exclusive development and commercialization rights in China and several countries in the Asia Pacific region to CRESEMBA (isavuconazole).

  December 1, 2017

   · 

  9 min read
• Business

  Evotec Receives Clinical Milestone As Part of Its Discovery Alliance With Boehringer Ingelheim

  Evotec AG announced today that it has achieved a clinical milestone under its drug discovery alliance with Boehringer Ingelheim triggering revenues of EUR 2.00 m to Evotec.

  December 1, 2017

   · 

  4 min read